Skip to main content
Log in

Adalimumab/infliximab/vedolizumab

Guillain Barre syndrome: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • de Azevedo MFC, et al. Guillain-Barre Syndrome in a Crohn`s Disease Patient Treated With Vedolizumab. Journal of Crohn's and Colitis 14: 1788-1789, No. 12, Dec 2020. Available from: URL: http://doi.org/10.1093/ecco-jcc/jjaa101

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/infliximab/vedolizumab. Reactions Weekly 1896, 21 (2022). https://doi.org/10.1007/s40278-022-10812-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-10812-9

Navigation